Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Uncover strategies to earn passive income even as you manage debt. These methods can help you create a more stable financial future.
27,703 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
OpenAI CEO Sam Altman and Anthropic CEO Dario Amodei avoided a handshake at the India AI Impact Summit, signaling a w...
CrowdStrike has pulled back from recent highs. Before March 3 earnings, investors wonder if a dip offers a real buyin...
A corporate insider recently sold a sizable block of Symbotic stock. This article breaks down what the sale means, ho...
Bitcoin liquidity tightens as the crypto native version money pool shrinks, signaling thinner market depth and sharpe...
A large holder trimmed a substantial stake in a biotech name while the stock advanced. This piece explains what inves...
OpenAI has redefined its mission and governance, moving into a for-profit structure and removing safety language from...
Amazon’s leadership chief argues trust is earned through honesty and accountability, not flattering bosses. The messa...
U.S. equities rebounded on Feb 24, 2026, led by AI optimism and a landmark Meta-AMD pact. Traders see the love-hate t...
When a CEO puts real money behind his own company’s stock, investors sit up and take notice. This article breaks down...
Brown Harris Stevens adds Debbie Baum, a seasoned Manhattan real estate broker, from Corcoran. The move expands the f...
A Harvard professor decodes the squeak that haunts basketball courts, tying micro-deformations in the sole to the son...